Inclusivity, Diversity & Equity is the Core of ACCP's Culture

 

The Mission & Vision of the American College of Clinical Pharmacology® (ACCP) includes providing innovative leadership and interdisciplinary education that will enable the generation, integration and translation of scientific knowledge to optimize the research, development and utilization of medication for the benefit of all. As an organization with a global membership, ACCP strives to embrace the unique nature of each individual in the international community it serves. From educating healthcare colleagues that span the breadth of the myriad of facets of the profession to ensuring safe and efficacious patient care, ACCP remains committed to promoting and adhering to fairness and equity.

Our culture is founded on inclusivity. From a diverse Board of Regents elected by the society’s Members to discounted membership fees for colleagues from developing countries to proudly supporting diversity among Faculty Speakers in educational programs and a concerted effort to provide opportunities and develop the skills of our younger colleagues, ACCP deliberately seeks to promote the field of clinical pharmacology to all who express an interest and share our values, regardless of ethnicity, age, gender, sexual orientation, religion or skill set. We endeavor to avoid unconscious bias and promote professionalism, courtesy and respect. This cannot be a static concept, but must instead be one by which we abide as we evolve and grow.

The Officers, Board of Regents, Staff and the membership of ACCP invite you to join us in serving our global community with dignity & integrity to prohibit discrimination & harassment and work together to achieve a better tomorrow.

Inclusivity, Diversity & Equity Committee

The main purpose of the IDE Committee is to implement guidances to ensure that ACCP is mindful of a social balance in its activities and programming that provides an atmosphere of opportunity for all persons in the society. This will allow ACCP to effectively meet the needs of its Members, engage them in society activities and attract new Members to whom the opportunities appeal. For more information on the Committee and its role please view the Inclusivity, Diversity & Equity Committee Charter.

2022 - 2024 IDE Committee

View video statements from committee members about the importance of the IDE Committee.

 

2022 - 2024 Committee Workplan

  1. Create a video tutorial or voice over PowerPoint presentation about what defines a reportable incident and how to report such an incident at ACCP. This will address the need identified in the 2022 membership survey.
  2. Create and promote the capacity on the website to report a positive experience at ACCP through sharing personal perspectives and experiences.
  3. The results of the IDE Survey indicated the importance of further highlighting IDE in clinical trials, including pediatrics, that moves past enrolling a diverse population for the clinical trial to the later impact on diversity. The committee will develop a webinar on the impact of diversity from the consumer perspective, including the use of case studies and interactive panel with consumer representatives and organizations, to present in ~April of 2023.
  4. Develop of a Proposal for 2024 ACCP Annual Meeting on IDE session in drug development.
  5. A third education event will be developed during the term.
  6. The committee will continue hosting the IDE Booth in the Exhibit Hall at the 2023 ACCP Annual Meeting that may include iPad quizzes about IDE at ACCP.
  7. The committee will strive to develop and publish manuscripts, as appropriate, to support/reflect educational sessions.